Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn’s disease: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn’s disease: a case report ; day:2 ; month:11 ; year:2024 ; pages:1-5
CEN Case Reports ; (2.11.2024), 1-5
- Urheber
-
Alghamdi, Naif
Alshehri, Fahad
Alhazza, Sultan
Bhutto, Fahad
Alhassan, Azhari
Kechrid, Mohammed
Alshehri, Dhafer
Alshammari, Kadi
Assiri, Talal
Assiri, Ohoud
Darewsh, Emad
Ali, Mohammed
Qadri, Ruba
Alahmadi, Yasser
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13730-024-00943-6
- URN
-
urn:nbn:de:101:1-2501212119104.009696488681
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 26.03.2202, 00:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alghamdi, Naif
- Alshehri, Fahad
- Alhazza, Sultan
- Bhutto, Fahad
- Alhassan, Azhari
- Kechrid, Mohammed
- Alshehri, Dhafer
- Alshammari, Kadi
- Assiri, Talal
- Assiri, Ohoud
- Darewsh, Emad
- Ali, Mohammed
- Qadri, Ruba
- Alahmadi, Yasser
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
IgG4-related tubulointerstitial nephritis accompanied with cystic formation
CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
Duodenal Crohn’s disease successfully treated with adalimumab
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
IgG4-related tubulointerstitial nephritis accompanied with cystic formation
CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
Duodenal Crohn’s disease successfully treated with adalimumab
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
IgG4-related tubulointerstitial nephritis accompanied with cystic formation
CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study